Can you provide the average price target for RELIANCE INC stock?
18 analysts have analysed RS and the average price target is 334.92 USD. This implies a price increase of 11.09% is expected in the next year compared to the current price of 301.475.
NYSE:RS • US7595091023
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RELIANCE INC (RS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-20 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2026-02-20 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-20 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-12-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-10-24 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-09 | JP Morgan | Initiate | Overweight |
| 2025-08-14 | Wells Fargo | Initiate | Equal-Weight |
| 2025-02-24 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-01-22 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-12-02 | Goldman Sachs | Initiate | Neutral |
| 2024-10-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-14 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-07-26 | Wolfe Research | Downgrade | Peer Perform -> Underperform |
| 2024-07-03 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-06-26 | B of A Securities | Maintains | Neutral -> Neutral |
| 2024-04-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-11 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-02-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-02-16 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-10-27 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-10-17 | Keybanc | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.806B -13.03% | 13.835B -6.56% | 14.294B 3.32% | 15.626B 9.32% | 15.799B 1.11% | 16.333B 3.38% | |
| EBITDA YoY % growth | 1.985B -27.99% | 1.455B -26.71% | 1.319B -9.31% | 1.576B 19.46% | 1.67B 5.96% | 1.668B -0.12% | |
| EBIT YoY % growth | 1.74B -30.87% | 1.186B -31.82% | 1.041B -12.22% | 1.284B 23.33% | 1.355B 5.53% | 1.362B 0.52% | |
| Operating Margin | 11.75% | 8.57% | 7.28% | 8.22% | 8.58% | 8.34% | |
| EPS YoY % growth | 22.58 -24.53% | 15.81 -29.98% | 14.24 -9.93% | 18.10 27.09% | 19.86 9.72% | 19.78 -0.41% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 4.78 26.87% | 5.09 14.90% | 4.33 19.06% | 3.20 33.47% |
| Revenue Q2Q % growth | 4.008B 15.02% | 4.012B 9.62% | 3.818B 4.57% | 3.496B -0.07% |
| EBITDA Q2Q % growth | 414.42M 20.79% | 427.93M -6.34% | 385.2M -17.96% | 299.39M -34.55% |
| EBIT Q2Q % growth | 340.72M 24.17% | 361.22M 13.41% | 311.74M 19.62% | 220.42M 23.00% |
All data in USD
18 analysts have analysed RS and the average price target is 334.92 USD. This implies a price increase of 11.09% is expected in the next year compared to the current price of 301.475.
RELIANCE INC (RS) will report earnings on 2026-04-22.
The consensus EPS estimate for the next earnings of RELIANCE INC (RS) is 4.78 USD and the consensus revenue estimate is 4.01B USD.
The number of analysts covering RELIANCE INC (RS) is 18.